IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,521 | +10.6% | 739 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $30,321 | +15.1% | 739 | +0.3% | 0.01% | 0.0% |
| Q1 2023 | $26,340 | -4.9% | 737 | +0.5% | 0.01% | 0.0% |
| Q4 2022 | $27,685 | -16.1% | 733 | -0.8% | 0.01% | -28.6% |
| Q3 2022 | $33,000 | +22.2% | 739 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $27,000 | -10.0% | 739 | -10.1% | 0.01% | +20.0% |
| Q1 2022 | $30,000 | +130.8% | 822 | +94.3% | 0.01% | +150.0% |
| Q4 2021 | $13,000 | -13.3% | 423 | -3.6% | 0.00% | -33.3% |
| Q3 2021 | $15,000 | +200.0% | 439 | +262.8% | 0.00% | +200.0% |
| Q2 2021 | $5,000 | -28.6% | 121 | -18.2% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | -56.2% | 148 | -50.0% | 0.00% | -50.0% |
| Q4 2020 | $16,000 | +45.5% | 296 | +23.8% | 0.00% | -33.3% |
| Q3 2020 | $11,000 | 0.0% | 239 | +22.6% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | +83.3% | 195 | +57.3% | 0.00% | +50.0% |
| Q1 2020 | $6,000 | -50.0% | 124 | -39.5% | 0.00% | -60.0% |
| Q4 2019 | $12,000 | 0.0% | 205 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $12,000 | -7.7% | 205 | +1.0% | 0.01% | 0.0% |
| Q2 2019 | $13,000 | -18.8% | 203 | +1.5% | 0.01% | -28.6% |
| Q1 2019 | $16,000 | +220.0% | 200 | +100.0% | 0.01% | +133.3% |
| Q4 2018 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,000 | -20.0% | 100 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $4,000 | -71.4% | 100 | -65.0% | 0.00% | -70.0% |
| Q4 2016 | $14,000 | +250.0% | 286 | +186.0% | 0.01% | +233.3% |
| Q3 2016 | $4,000 | +100.0% | 100 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $2,000 | -50.0% | 100 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $4,000 | -33.3% | 100 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $6,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |